Atezolizumab for Advanced Alveolar Soft Part Sarcoma is a research paper published in New England Journal of Medicine (2023). On theSindex it has a DataRank of 3.3. It has been cited 158 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.760
From this paper's citation signal
Citation Network Contribution
2.5
From 91 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
National Cancer Institute
Grant: Contract No. 75N91019D00024
NCI NIH HHS
Grant: 75N91019D00024
NCI NIH HHS
Grant: UM1 CA186709
NCI NIH HHS
Grant: P30 CA016058
NCI NIH HHS
Grant: UM1 CA186712
Intramural NIH HHS
Grant: Z99 CA999999
NCI NIH HHS
Grant: UM1 CA186690
NCI NIH HHS
Grant: UM1 CA186717
NCATS NIH HHS
Grant: UL1 TR001863
NCI NIH HHS
Grant: UM1 CA186691
NCI NIH HHS
Grant: UM1 CA186688
Genentech Inc.
MeSH Terms